Immunohistochemical expression of estrogene, progesterone receptors, CerbB2 and BRCA1 in ovarian carcinoma and their prognostic value

被引：0
|
作者：
Gursoy, D. [1 ]
Gurses, I. [1 ]
Dunikan, H. [1 ]
Ozcomert, B. [1 ]
Tasdelen, B. [1 ]
Arican, A. [1 ]
Tok, F. [1 ]
机构：
[1] Van Educ Res Hosp, Dept Pathol, Van, Turkey
来源：
VIRCHOWS ARCHIV | 2016年 / 469卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
EPS-07-056
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [41] Prognostic Significance of Aurora-A and BRCA2 Expression in Endometrioid Ovarian Carcinoma
    Yang, F.
    Guo, X.
    Yang, G.
    Rosen, D. G.
    Liu, J.
    LABORATORY INVESTIGATION, 2011, 91 : 271A - 271A
  • [42] BRCA1/2 TESTING RATES IN EPITHELIAL OVARIAN CARCINOMA: A FOCUS ON THE UNTESTED PATIENTS
    Lanjouw, Lieke
    Mourits, Marian
    Bart, Joost
    Ter Elst, Arja
    Berger, Lieke
    Van der Hout, Annemieke
    Alam, Naufil
    De Bock, Geertruida
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A160 - A160
  • [43] BRCA1 and MAD2 Are Coexpressed and Are Prognostic Indicators in Tubo-ovarian High-Grade Serous Carcinoma
    Byrne, Tara
    Nelson, Laura
    Beirne, James P.
    Sharpe, Daniel
    Quinn, Jennifer E.
    McCluggage, W. Glenn
    Robson, Tracy
    Furlong, Fiona
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (03) : 472 - 478
  • [44] Prognostic Effect of Ductal Carcinoma in Situ in Breast Cancer with BRCA1/2 Mutations
    Yoon, Kyung-Hwak
    Kim, Eun-Kyu
    Shin, Hee-Chul
    CANCER RESEARCH, 2024, 84 (09)
  • [45] Factors associated with genetic testing in BRCA1 and BRCA2 mutation carriers with advanced ovarian carcinoma
    Norquist, B.
    Walsh, T.
    Pennil, C.
    Lee, M. K.
    Casadei, S.
    Thornton, A. M.
    Nord, A. S.
    Garcia, R.
    King, M. C.
    Swisher, E.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 435 - 435
  • [46] The expression and mutation of BRCA1/2 genes in ovarian cancer: a global systematic study
    Chu, Dinh-Toi
    Vu Ngoc Suong, Mai
    Vu Thi, Hue
    Vu, Thuy-Duong
    Nguyen, Manh-Hung
    Singh, Vijai
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2023, 23 (01) : 53 - 61
  • [47] Immunohistochemical Expression of BRCA1 and BRCA2 in Prostate Cancer: A Cross-Sectional Study in Kampala, Uganda
    Amsi, P.
    Yahaya, J.
    Kalungi, S.
    Odida, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (05): : S51 - S51
  • [48] Expression of Androgen receptors in Breast carcinomas of patients for BRCA1 and BRCA2 Mutation Testing.
    Pristauz, G.
    Petru, E.
    Stacher, E.
    Geigl, J. B.
    Schwarzbraun, T.
    Tsybrovvskyy, O.
    Winter, R.
    Moinfar, F.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2010, 70 (05) : 427 - 427
  • [49] Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas
    Moes-Sosnowska, Joanna
    Rzepecka, Iwona K.
    Chodzynska, Joanna
    Dansonka-Mieszkowska, Agnieszka
    Szafron, Lukasz M.
    Balabas, Aneta
    Lotocka, Renata
    Sobiczewski, Piotr
    Kupryjanczyk, Jolanta
    CANCER BIOLOGY & THERAPY, 2019, 20 (06) : 843 - 854
  • [50] Characteristics of women with ovarian carcinoma who have BRCA1 and BRCA2 mutations not identified by clinical testing
    Norquist, Barbara M.
    Pennington, Kathryn P.
    Agnew, Kathy J.
    Harrell, Maria I.
    Pennil, Christopher C.
    Lee, Ming K.
    Casadei, Silvia
    Thornton, Anne M.
    Garcia, Rochelle L.
    Walsh, Tom
    Swisher, Elizabeth M.
    GYNECOLOGIC ONCOLOGY, 2013, 128 (03) : 483 - 487
12345